Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma

Sponsor
Hackensack Meridian Health (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05723328
Collaborator
American Music Therapy Association (Other)
100
1
2
24
4.2

Study Details

Study Description

Brief Summary

This study will use a systematic music therapy intervention on patients with mental illness trying to help them with their internalized stigma.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Group Music Therapy Advocacy Recording Intervention (MTAR)
N/A

Detailed Description

The primary objective of this study is to determine the effect of a systematic music therapy intervention on internalized stigma of mental illness. The secondary objective is to evaluate the potential for the treatment effect to vary across subject diagnostic categories. This study will also examine the ability of the treatment effect to persist after 3 weeks as an exploratory objective.

Data collection will be conducted in the Acute Care Unit (ACU) of Hackensack Meridian Health Carrier Clinic (HMHCC) over a period of ten months. Subjects will be drawn from the pool of patients admitted to the HMHCC ACU during that time. Adults aged 18-65 with severe mental illness with a diagnosis of bipolar or a related disorder, depressive or anxiety disorder, or schizophrenia spectrum or other psychotic disorders as defined by the Diagnostic and Statistical Manual of Mental Disorders version 5 (DSM-5 : 5th ed.; American Psychiatric Association, 2013), of prolonged duration with a significant degree of disability or social dysfunction (Ruggeri et al., 2000) are eligible to participate. Eligible participants must be able to provide informed consent as determined by the doctor.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Pseudo cluster randomized controlled design (Borm et al., 2005) will take advantage of the unit's two separate residential areasPseudo cluster randomized controlled design (Borm et al., 2005) will take advantage of the unit's two separate residential areas
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effect of a Group Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma in Adult Psychiatric Inpatients in Acute Care
Anticipated Study Start Date :
Mar 15, 2023
Anticipated Primary Completion Date :
Mar 14, 2025
Anticipated Study Completion Date :
Mar 14, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment Group

The intervention consists of a sequence of five music therapy song-writing and recording groups, one per day. Internalized stigma will be assessed within 3 days of admission (pretest/baseline), at ten days (posttest), and at 3 weeks from baseline (follow-up), using the Internalized Stigma of Mental Illness Inventory.

Behavioral: Group Music Therapy Advocacy Recording Intervention (MTAR)
Music Therapy Advocacy Recording Intervention (MTAR) is a sequence of group music therapy song-writing and recording sessions framed as a mental health awareness project to be shared with the general public.

No Intervention: Control Group

Access to standard of care services that include several groups per day focused on topics of coping skills, mindfulness, journaling, creative arts, wellness recovery, recreation, and at least one music therapy group.

Outcome Measures

Primary Outcome Measures

  1. Change in the Internalized Stigma of Mental Illness Inventory (ISMI) score between pre and post MTAR [Post MTAR intervention (day 8-10)]

    The Internalized Stigma of Mental Illness Inventory will be administered before and after the MTAR intervention and the change in the score will be reported. Primary outcome will be reported only for the treatment arm. The internalized stigma of mental illness inventory is a 29 item questionnaire. Items are scored on a 1-4 scale, with the total scale score calculated as a sum of the items then dividing by the total number of answered items.

Secondary Outcome Measures

  1. Change in the ISMI score based on diagnostic category [Post MTAR intervention (day 8-10)]

    Change in the Internalized Stigma of Mental Illness Inventory (ISMI) score between pre and post MTAR across subject diagnostic categories. ISMI scores will be compared between subjects with no diagnosis or diagnosed with schizophrenia spectrum and other psychotic disorders, bipolar and related disorders, depressive disorders, and anxiety disorders, as classified by the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders - 5th edition (DSM-5; American Psychiatric Association, 2013). The internalized stigma of mental illness inventory is a 29 item questionnaire. Items are scored on a 1-4 scale, with the total scale score calculated as a sum of the items then dividing by the total number of answered items.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Admitted to the HMHCC ACU

  • Able to read and comprehend the ISMI questionnaire, provide informed consent,

  • With a severe mental illness of prolonged duration with a significant degree of disability or social dysfunction

Exclusion Criteria:
  • Patients on S1 status (1:1 patient observation) or isolation protocol

  • Evidence of organic brain disease, severe acute symptomatology, hearing deficit, and intellectual disability.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Carrier Clinic Belle Mead New Jersey United States 08502

Sponsors and Collaborators

  • Hackensack Meridian Health
  • American Music Therapy Association

Investigators

  • Principal Investigator: Zachary D Fischer, PhD, MT-BC, Hackensack Meridian Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hackensack Meridian Health
ClinicalTrials.gov Identifier:
NCT05723328
Other Study ID Numbers:
  • Pro2022-0570
First Posted:
Feb 10, 2023
Last Update Posted:
Feb 13, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hackensack Meridian Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 13, 2023